Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$43.68

-0.7 (-1.58%)

13:45
05/16/18
05/16
13:45
05/16/18
13:45

Ionis Pharmaceuticals has a conferenced call hosted by JPMorgan

JPMorgan Analyst Fye will host a conference call with COO Brett Monia on May 16 at 2 pm.

  • 16

    May

  • 23

    May

  • 06

    Jul

  • 30

    Aug

  • 06

    Oct

IONS Ionis Pharmaceuticals
$43.68

-0.7 (-1.58%)

05/08/18
05/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Comcast (CMCSA) downgraded to Neutral from Overweight at Atlantic Equities. 2. Zillow (Z, ZG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Mahaney citing the recent stock price appreciation. 3. XL Group (XL) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Dwelle saying the company's first quarter earnings did not contain any red flags around the sale of the company to AXA (AXAHY), which is on track to close in late second quarter or in the third quarter. 4. Ionis Pharmaceuticals (IONS) downgraded to In Line from Outperform at Evercore ISI with analyst Josh Schimmer citing the safety concerns around volanesorsen discussed in the latest FDA briefing documents, which also "dismantled the company's claims" that the treatment leads to benefits in pancreatis. 5. Sapiens (SPNS) downgraded to Market Perform from Outperform at William Blair with analyst Justin Furby saying consensus estimates for 2019 could be a "too aggressive." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/18
EVER
05/08/18
DOWNGRADE
Target $46
EVER
In Line
Ionis Pharmaceuticals cut to In Line at Evercore ISI after volanesorsen review
As reporter earlier, Evercore ISI analyst Josh Schimmer downgraded Ionis Pharmaceuticals to In Line from Outperform and lowered his price target to $46 from $55. The analyst cites the safety concerns around volanesorsen discussed in the latest FDA briefing documents, which also "dismantled the company's claims" that the treatment leads to benefits in pancreatis. Schimmer says that while he did not assign much value around volanesorsen, he is now removing it from the model until there is more certainty around the drug profile while also increasing the discount rate to reflect additional platform uncertainty.
05/08/18
EVER
05/08/18
DOWNGRADE
EVER
In Line
Ionis Pharmaceuticals downgraded to In Line from Outperform at Evercore ISI
04/24/18
EVER
04/24/18
NO CHANGE
EVER
Outperform
Spinraza decline in new adds happened 'a bit early,' says Evercore ISI
Commenting on weakness in shares of Ionis Pharmaceuticals (IONS), Evercore ISI analyst Josh Schimmer said he knew Spinraza new adds would start to decline at some point, leading to a sequential drop in injections, but this happened "a bit early." Following Biogen's (BIIB) report, he sees potential for Spinraza stagnation in the U.S. this year, with growth driven outside of the U.S. In terms of the Huntington's data for Ionis' antisense program partnered with Roche (RHHBY) presented today, Schimmer said there were "encouraging signs for some of the disease measures, less encouraging for others" along with "generally wide error bars." He has an Outperform rating on Ionis, which is down 11% to $45.06 in afternoon trading.

TODAY'S FREE FLY STORIES

GTHX

G1 Therapeutics

$19.56

-0.56 (-2.78%)

07:21
01/23/19
01/23
07:21
01/23/19
07:21
Downgrade
G1 Therapeutics rating change  »

G1 Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIDX

Eidos Therapeutics

$12.64

-0.04 (-0.32%)

07:20
01/23/19
01/23
07:20
01/23/19
07:20
Downgrade
Eidos Therapeutics rating change  »

Eidos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXCYY

Metso

$0.00

(0.00%)

07:20
01/23/19
01/23
07:20
01/23/19
07:20
Hot Stocks
Metso's Shareholders' Nomination Board to propose Mikael Lilius as chair »

Metso's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$7.76

-0.47 (-5.71%)

07:20
01/23/19
01/23
07:20
01/23/19
07:20
Downgrade
Dova Pharmaceuticals rating change  »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 30

    Jun

APLS

Apellis

$13.46

-1.42 (-9.54%)

07:19
01/23/19
01/23
07:19
01/23/19
07:19
Downgrade
Apellis rating change  »

Apellis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$298.80

-3.46 (-1.14%)

07:18
01/23/19
01/23
07:18
01/23/19
07:18
Downgrade
Tesla rating change  »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

IP

International Paper

$45.69

0.03 (0.07%)

07:15
01/23/19
01/23
07:15
01/23/19
07:15
Upgrade
International Paper rating change  »

Stephens says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

EHTH

eHealth

$45.38

-0.85 (-1.84%)

07:15
01/23/19
01/23
07:15
01/23/19
07:15
Recommendations
eHealth analyst commentary  »

eHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

07:15
01/23/19
01/23
07:15
01/23/19
07:15
General news
FX Update: The dollar has traded flat-to-softer »

FX Update: The dollar has…

MAS

Masco

$31.00

-1.21 (-3.76%)

07:13
01/23/19
01/23
07:13
01/23/19
07:13
Initiation
Masco initiated  »

Masco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

HII

Huntington Ingalls

$196.46

-3.82 (-1.91%)

07:13
01/23/19
01/23
07:13
01/23/19
07:13
Downgrade
Huntington Ingalls rating change  »

Barclays double…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:12
01/23/19
01/23
07:12
01/23/19
07:12
Hot Stocks
Breaking Hot Stocks news story on Comcast »

Comcast up 3.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:11
01/23/19
01/23
07:11
01/23/19
07:11
Hot Stocks
Comcast raises annualized dividend by 10% to 84c per share »

Comcast announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

MTG

MGIC Investment

$11.63

-0.15 (-1.27%)

07:10
01/23/19
01/23
07:10
01/23/19
07:10
Hot Stocks
MGIC Investment announces executive promotions »

MGIC Investment's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

UTX

United Technologies

$111.23

-2.7 (-2.37%)

07:10
01/23/19
01/23
07:10
01/23/19
07:10
Hot Stocks
United Technologies up over 4.5% after Q4 earnings beat, initial FY19 guidance »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Hot Stocks
Comcast reports Q4 pro-forma revenue for Sky up 2.4% to $5B »

Pro Forma Revenue for Sky…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CPA

Copa Holdings

$88.31

-3.84 (-4.17%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Upgrade
Copa Holdings rating change  »

Copa Holdings upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Hot Stocks
Comcast reports Q4 NBCUniversal revenue $9.4B vs. $8.77B last year »

Revenue for NBCUniversal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

WSM

Williams-Sonoma

$52.51

-1.26 (-2.34%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Downgrade
Williams-Sonoma rating change  »

Morgan Stanley downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$128.76

-1.89 (-1.45%)

07:08
01/23/19
01/23
07:08
01/23/19
07:08
Periodicals
Johnson & Johnson pursuing acquisition of Auris Health, Bloomberg reports »

Johnson & Johnson is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 18

    Feb

CMCO

Columbus McKinnon

$33.82

-0.39 (-1.14%)

07:08
01/23/19
01/23
07:08
01/23/19
07:08
Initiation
Columbus McKinnon initiated  »

Columbus McKinnon resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

MTBC

Medical Transcription Billing

$4.36

-0.12 (-2.68%)

07:07
01/23/19
01/23
07:07
01/23/19
07:07
Recommendations
Medical Transcription Billing analyst commentary  »

Medical Transcription…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$90.50

-0.89 (-0.97%)

07:07
01/23/19
01/23
07:07
01/23/19
07:07
Earnings
Procter & Gamble reaffirms FY19 core EPS growth of 3%-8% vs. FY18 »

Consensus $4.42. "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

  • 03

    Mar

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:07
01/23/19
01/23
07:07
01/23/19
07:07
Hot Stocks
Comcast reports Q4 high-speed internet customer net additions 351,000 »

Total Customer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

07:07
01/23/19
01/23
07:07
01/23/19
07:07
General news
MBA Mortgage Applications Composite Index data reported »

Week of 1/18 MBA Mortgage…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.